Designing A Measurable, Outcome-Driven Value-Based Care Model: The Community Health Network (MyCHN) Case Study is starting in

Reckitt Benckiser, Inc., First Quarter 2009 Results

April 28, 2009 This is a report on first quarter 2009 results from Reckitt Benckiser, which markets Suboxone and Subutex, formulations of buprenorphine, through its pharmaceuticals division. The two medications are used for outpatient treatment of opioid addiction. The medications will lose patent protection in October 2009. This report discusses Reckitt Benckiser's plans. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.